You are here

avelumab

Merck KGaA and Pfizer say drug failed to meet primary endpoints in late-stage ovarian cancer trial

Marketwatch

Mon, 11/19/18 - 09:59 am

clinical trials

Immunicum Announces Collaboration with Merck KGaA and Pfizer to Evaluate Cell Therapy Treatment in Combination with Avelumab

CP Wire

Fri, 11/16/18 - 10:10 am

immuno-oncology

Leap Therapeutics To Collaborate With Merck, Pfizer To Evaluate TRX518

Business Insider

Mon, 07/23/18 - 10:44 pm

Leap Therapeutics

Move over, AstraZeneca. Pfizer and Merck KGaA are the newest bladder cancer drugmakers in town

Fierce Pharma

Wed, 05/10/17 - 09:31 am

Pfizer, Merck KGaA fourth to market with PD-1/L1 inhibitor

BioPharma Dive

Sun, 03/26/17 - 12:00 pm

FDA approves Pfizer, German Merck immunotherapy for skin cancer

Yahoo/Reuters

Fri, 03/24/17 - 09:38 am

metastatic Merkel cell carcinoma

Pfizer, Merck KGaA Delay Lung Cancer Drug Trial Outcome

Investopedia

Mon, 03/20/17 - 10:54 am

clinical trials

non-small cell lung cancer

Merck KGaA, Pfizer get priority review for bladder cancer drug

Yahoo/Reuters

Tue, 02/28/17 - 10:22 am

German Merck, Pfizer get FDA priority review for cancer drug

Yahoo/Reuters

Tue, 11/29/16 - 09:55 am

Merkel cell carcinoma

Is This Pfizer's Next Mega-Blockbuster Cancer Drug?

Motley Fool

Tue, 09/27/16 - 10:51 am

Recent Corporate and Pipeline Developments for Pfizer

Market Realist

Mon, 08/15/16 - 11:07 am

Bamboo Therapeutics

Western Oncolytics

Can Pfizer Make Headway In A Rare Skin Tumor?

Seeking Alpha

Tue, 07/19/16 - 09:42 am

Merkel cell carcinoma

Pfizer, Germany's Merck begin large ovarian cancer trial

Yahoo/Reuters

Thu, 07/7/16 - 09:25 am

Merck and Pfizer Initiate Phase III Trial to Evaluate Avelumab as First-line Treatment for Ovarian Cancer

Yahoo

Wed, 07/6/16 - 10:58 am

Pfizer, Merck begin triple-drug immuno-oncology study

BioPharma Dive

Wed, 05/11/16 - 10:43 am

immuno-oncology

Merck, Pfizer and Verastem Announce Combination Trial of Avelumab and VS-6063 in Ovarian Cancer

Yahoo

Thu, 03/3/16 - 10:44 am

clinical trials

Pfizer, Merck KGaA launch two more PhIII trials for avelumab

Fierce Biotech

Tue, 12/22/15 - 10:00 pm

The Path Is Clear for a New Immunotherapy Entrant

Motley Fool

Tue, 12/1/15 - 02:16 pm

Merck KGaA, Pfizer widen development of cancer immunology drug

Yahoo/Reuters

Wed, 11/4/15 - 02:05 pm

cancer immunotherapy

Merck KGaA sees immunotherapy drug holding its own in cancer race

Yahoo/Reuters

Tue, 06/2/15 - 09:06 am

cancer immunotherapy